Elisa Agostinetto: EBCTCG analysis showing a major in recurrence rates for breast cancer clinical trials between 1990-2009

Elisa Agostinetto shared a post on X:

”Out in The Lancet an EBCTCG analysis showing a major in recurrence rates for patients with early breast cancer enrolled in clinical trials between 1990-2009.”

Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials

Dr. Elisa Agostinetto is a medical oncologist, specializing in breast cancer research. Elisa Agostinetto is a Medical Research Fellow at the University Hospital of Brussels since November 2021. Additionally, she has serves as a Clinical Research Fellow at Jules Bordet Institute.

Her work focuses on clinical research in oncology, likely involving various aspects of cancer treatment and patient care. Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.